REN; Baoyong

Patent Applications and Registrations

Patent applications and USPTO patent grants for REN; Baoyong.The latest application filed is for "bispecific antigen-binding construct and preparation method and use thereof".

Company Profile

7.7.8

REN; Baoyong - Suzhou CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific Antigen-binding Construct And Preparation Method And Use Thereof App 20220251238 - LI; Huashun ; et al.	2022-08-11
Bispecific antigen-binding construct and preparation method and use thereof Grant 11,339,225 - Li , et al. May 24, 2	2022-05-24
PD-1 CAR NK-92 cell and preparation method and use thereof Grant 11,331,345 - Li , et al. May 17, 2	2022-05-17
Slit2D2-chimeric antigen receptor and application thereof Grant 11,246,888 - Li , et al. February 15, 2	2022-02-15
Fusion protein Slit2D2(C386S)-HSA and use thereof in prevention and/or treatment of lung inflammation Grant 11,149,071 - Li , et al. October 19, 2	2021-10-19
Slit2D2-HSA fusion protein and use thereof against tumours Grant 11,041,157 - Li , et al. June 22, 2	2021-06-22
Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases Grant 10,947,296 - Li , et al. March 16, 2	2021-03-16
Nucleotide Sequences For Encoding Car, Robo1 Car-nk Cells Of Expressing The Car, And Preparation And Application Thereof App 20200289573 - LI; Huashun ; et al.	2020-09-17
Fusion Protein Slit2d2(c386s)-hsa And Use Thereof In Prevention And/or Treatment Of Lung Inflammation App 20200087362 - LI; Huashun ; et al.	2020-03-19
Fusion Protein Slit2d2(c386s)-hsa And Use Thereof In Treatment Of Fibrotic Diseases App 20190309050 - Li; Huashun ; et al.	2019-10-10
Pd-1 Car Nk-92 Cell And Preparation Method And Use Thereof App 20190240258 - LI; Huashun ; et al.	2019-08-08
Slit2d2-chimeric Antigen Receptor And Application Thereof App 20190231819 - LI; Huashun ; et al.	2019-08-01
Fusion protein SLIT2D2-HSA and its use in treatment of sepsis Grant 10,336,813 - Li , et al.	2019-07-02
Slit2d2-hsa Fusion Protein And Use Thereof Against Tumours App 20180163214 - Li; Huashun ; et al.	2018-06-14
Fusion Protein Slit2d2-hsa And Its Use In Treatment Of Sepsis App 20180094045 - LI; Huashun ; et al.	2018-04-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.